We provide you with 20 years of free, institutional-grade data for EVOK stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of EVOK. Explore the full financial landscape of EVOK stock.
| Reported Date | CIK | Ticker | Type | |
|---|---|---|---|---|
| 2024-11-07 | 1403708 | EVOK | 10-Q | Url |
| 2024-08-13 | 1403708 | EVOK | 10-Q | Url |
| 2024-05-14 | 1403708 | EVOK | 10-Q | Url |
| 2024-03-14 | 1403708 | EVOK | 10-K | Url |
| 2023-11-09 | 1403708 | EVOK | 10-Q | Url |
| 2023-11-09 | 1403708 | EVOK | S-1 | Url |
| 2023-08-10 | 1403708 | EVOK | 10-Q | Url |
| 2023-05-15 | 1403708 | EVOK | 10-Q | Url |
| 2023-03-21 | 1403708 | EVOK | 10-K | Url |
| 2022-11-09 | 1403708 | EVOK | 10-Q | Url |
| 2022-08-10 | 1403708 | EVOK | 10-Q | Url |
| 2022-05-10 | 1403708 | EVOK | 10-Q | Url |
| 2022-03-08 | 1403708 | EVOK | 10-K | Url |
| 2021-11-10 | 1403708 | EVOK | 10-Q | Url |
| 2021-08-12 | 1403708 | EVOK | 10-Q | Url |
| 2021-05-12 | 1403708 | EVOK | 10-Q | Url |
| 2021-03-11 | 1403708 | EVOK | 10-K | Url |
| 2020-11-10 | 1403708 | EVOK | 10-Q | Url |
| 2020-08-06 | 1403708 | EVOK | 10-Q | Url |
| 2020-05-12 | 1403708 | EVOK | 10-Q | Url |
| 2020-03-12 | 1403708 | EVOK | 10-K | Url |
| 2019-11-07 | 1403708 | EVOK | 10-Q | Url |
| 2019-08-08 | 1403708 | EVOK | 10-Q | Url |
| 2019-05-08 | 1403708 | EVOK | 10-Q | Url |
| 2019-03-06 | 1403708 | EVOK | 10-K | Url |
| 2018-11-13 | 1403708 | EVOK | 10-Q | Url |
| 2018-08-09 | 1403708 | EVOK | 10-Q | Url |
| 2018-05-14 | 1403708 | EVOK | 10-Q | Url |
| 2018-03-07 | 1403708 | EVOK | 10-K | Url |
| 2017-11-14 | 1403708 | EVOK | 10-Q | Url |
| 2017-08-14 | 1403708 | EVOK | 10-Q | Url |
| 2017-05-15 | 1403708 | EVOK | 10-Q | Url |
| 2017-03-15 | 1403708 | EVOK | 10-K | Url |
| 2016-11-09 | 1403708 | EVOK | 10-Q | Url |
| 2016-08-15 | 1403708 | EVOK | 10-Q | Url |
| 2016-05-11 | 1403708 | EVOK | 10-Q | Url |
| 2016-03-10 | 1403708 | EVOK | 10-K | Url |
| 2015-11-12 | 1403708 | EVOK | 10-Q | Url |
| 2015-08-13 | 1403708 | EVOK | 10-Q | Url |
| 2015-05-14 | 1403708 | EVOK | 10-Q | Url |
| 2015-03-04 | 1403708 | EVOK | 10-K | Url |
| 2014-11-13 | 1403708 | EVOK | 10-Q | Url |
| 2014-08-13 | 1403708 | EVOK | 10-Q | Url |
| 2014-05-13 | 1403708 | EVOK | 10-Q | Url |
| 2014-03-25 | 1403708 | EVOK | 10-K | Url |
| 2013-11-13 | 1403708 | EVOK | 10-Q | Url |
| 2013-05-24 | 1403708 | EVOK | S-1 | Url |
Evoke Pharma, Inc(NASDAQ:EVOK) 
Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase III clinical trials to treat sym...
Website: http://www.evokepharma.com
Founded: 2007
Full Time Employees: 5
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
The information provided in this report about EVOK stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.